Reinhart, Glenn A. et al
"The Novel, Clinical Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease." Journal of Pharmacology and Experimental Therapeutics
(2022):
JPET-AR-2022-001423.
Web. 24 Mar. 2023.
